European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 191-195, February 2008

Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: A single institution experience with 17 cases

  • F. Sellner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • Corresponding Author InformationCorresponding author. Sozialmedizinisches Zentrum Süd – Kaiser-Franz-Josef-Hospital, Surgical Department, Kundratstrasse 3, A-1100 Wien, Austria. Tel.: +43 (1) 60191 999 4185; fax: +43 (1) 60191 4109.
  • ,
  • B. Sobhian

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
  • ,
  • M. De Santis

      Affiliations

    • Medical Department III (Oncology), Kaiser-Franz-Josef-Hospital, Vienna, Austria
  • ,
  • J. Pont

      Affiliations

    • Medical Department III (Oncology), Kaiser-Franz-Josef-Hospital, Vienna, Austria
  • ,
  • St. Staettner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
  • ,
  • St. Sellner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
  • ,
  • J. Karner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
  • ,
  • M. Klimpfinger

      Affiliations

    • Institute of Pathology and Bacteriology, Kaiser-Franz-Josef-Hospital, Vienna, Austria

Accepted 12 March 2007.

Abstract 

Aim

To evaluate the influence of distinguishing between well and poorly differentiated nonfunctioning neuroendocrine pancreatic carcinomas (PC).

Method

Six well differentiated and 11 poorly differentiated nonfunctioning neuroendocrine PC were retrospectively analyzed for differences and compared with 340 ductal PC.

Results

1. There was no difference in pT categories between well differentiated and, poorly differentiated nonfunctioning neuroendocrine PC and ductal PC. 2. The rate of the pN1 category was lower in well differentiated lesions (20%) than in poorly differentiated lesions (66%) and in the ductal PC group (75%). 3. The outcome of patients with R0 resections was significantly better for well differentiated neuroendocrine PC with all patients alive than for poorly differentiated ones and for ductal PC (5-year survival rate 0% and 18%, respectively). 4. The outcome following R1/R2 resections for poorly differentiated neuroendocrine PC tended to be similar than for ductal PC (1-year survival rate 20% vs. 33%). 5. There was no difference in mean survival time (9 months) between poorly differentiated lesions and ductal PC after palliative procedures.

Conclusions

The better outcome of surgical treatment of nonfunctioning neuroendocrine PC vs. that of ductal PC was confined to well differentiated neuroendocrine lesions. For poorly differentiated lesions the outcome was as poor as for ductal PC. These results underscore the importance to distinguish between well and poorly differentiated nonfunctioning neuroendocrine PC.

Keywords: Neuroendocrine pancreatic carcinomas, Nonfunctioning, Well and poorly differentiated, Outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(07)00136-9

doi:10.1016/j.ejso.2007.03.008

European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 191-195, February 2008